QunaSys, the world鈥檚 leading developer of advanced algorithms in the field of chemistry, has successfully raised an impressive $11,100,000 in its latest funding round. Founded in 2018, QunaSys has consistently been at the forefront of harnessing the power of quantum computing to accelerate the applicability of quantum technologies. This recent influx of capital is set to further enhance the company鈥檚 innovative endeavors, specifically in developing cutting-edge quantum chemical calculation software that operates across multiple technology platforms. With an aim to maximize quantum computing benefits in diverse chemical industries, the funding will bolster QunaSys's capabilities in refining its software offerings and expanding its collaborations within the QPARC industry consortium and with esteemed academic and governmental research institutions. The capital will also facilitate the company in scaling its operations to meet the growing demand for quantum technology integration in various sectors, paving the way for breakthroughs that could revolutionize chemical-related industries. As QunaSys continues to lead the charge in quantum technology applicability, this funding marks a significant milestone in its mission to transform and elevate the field of chemistry through revolutionary computing paradigms.
QunaSys Secures $11 Million in Series B Funding to Accelerate Quantum Technology Innovation in Chemistry
Recently funded 路 $11.1M Series bTechnology/Software Development
Get the full QunaSys company profile
Access contacts, investors, buying signals & more
Other recently funded companies
View all
Aisot Technologies
Aisot Technologies is a Zurich-based AI company pioneering advanced, AI-driven investment solutions. Spun out of ETH Zurich in 2021, aisot leverages machine learning, large language models (LLMs), and quantitative methods to deliver precise, real-time investment insights. Its AI Insights Platform empowers asset managers, funds, family offices, and treasuries to anticipate market trends, optimize strategies, and mitigate risk. Recognized across Europe and the U.S., aisot partners with leading financial institutions to redefine quantitative investment management.
$2.5M Seed
today
Dognosis
Dognosis is a deep-tech startup in Bangalore decoding canine cognition to reveal the hidden world of scent. Our vision is a world where we have cracked the olfactory code of disease, making detecting disease as easy as breathing. Our mission is to save lives by detecting disease early and advance humanity towards truly proactive and preventative medicine. Our work revolves around increasing the bandwidth of human-canine collaboration, allowing us to catch the scent of disease at scale. Our first goal is to solve for early cancer detection by pioneering a multi-cancer breath-based test - BreathEasy - that will be ultra-affordable, highly accurate, and super accessible. We're always on the lookout for passionate and ambitious people to work with us. Feel free to say hi to woof@dognosis.tech
Other recent Series b rounds
Companies that recently closed a Series b round.
| # | Company | Round | Amount | Date |
|---|---|---|---|---|
| 1 |  NEW ID | Series b | $705.2K | today |
| 2 |  Arist United States | Series b | $14.1M | today |
| 3 |
